Non Small Cell Lung Cancer

New lung cancer test predicts survival

In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available ...

Jan 26, 2012
popularity 4.8 / 5 (5) | comments 0 | with audio podcast

Study finds new genetic error in some lung cancers

A fine-grained scan of DNA in lung cancer cells has revealed a gene fusion – a forced merger of two normally separate genes – that spurs the cells to divide rapidly, scientists at Dana-Farber Cancer Institute and the ...

Oct 28, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers find new drug target for lung cancer

Drugs targeting an enzyme involved in inflammation might offer a new avenue for treating certain lung cancers, according to a new study by scientists at the Salk Institute for Biological Studies.

Feb 16, 2012
popularity 5 / 5 (6) | comments 0 | with audio podcast

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

We drink more alcohol on gym days

A new Northwestern Medicine study finds that on days when people exercise more—typically Thursdays to Sundays—they drink more alcohol, too.

The fine line between breast cancer and normal tissues

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Reversing the effects of pulmonary fibrosis

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.